CBAY logo

CymaBay Therapeutics (CBAY) Working Capital

CBAY Annual Working Capital

$366.96 M
+$244.33 M+199.24%

31 December 2023

CBAY Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CBAY Quarterly Working Capital

$366.96 M
-$61.03 M-14.26%

31 December 2023

CBAY Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CBAY Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+199.2%-14.3%
3 y3 years+158.9%+158.9%
5 y5 years+119.5%+119.5%

CBAY Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall timeat high-14.3%

CymaBay Therapeutics Working Capital History

DateAnnualQuarterly
Dec 2023
$366.96 M(+199.2%)
$366.96 M(-14.3%)
Sept 2023
-
$427.99 M(+107.6%)
June 2023
-
$206.18 M(+5.1%)
Mar 2023
-
$196.22 M(+60.0%)
Dec 2022
$122.63 M(-29.0%)
$122.63 M(-13.9%)
Sept 2022
-
$142.41 M(-7.6%)
June 2022
-
$154.05 M(-13.5%)
Mar 2022
-
$178.01 M(+3.1%)
Dec 2021
$172.73 M(+21.9%)
$172.73 M(+60.2%)
Sept 2021
-
$107.83 M(+2.8%)
June 2021
-
$104.85 M(-16.4%)
Mar 2021
-
$125.36 M(-11.5%)
Dec 2020
$141.73 M(-23.5%)
$141.73 M(-9.0%)
Sept 2020
-
$155.67 M(-5.4%)
June 2020
-
$164.62 M(-5.4%)
Mar 2020
-
$174.03 M(-6.1%)
Dec 2019
$185.29 M(+10.9%)
$185.29 M(-11.9%)
Sept 2019
-
$210.41 M(-10.2%)
June 2019
-
$234.39 M(-8.3%)
Mar 2019
-
$255.59 M(+52.9%)
Dec 2018
$167.15 M
$167.15 M(-11.4%)
DateAnnualQuarterly
Sept 2018
-
$188.62 M(-5.6%)
June 2018
-
$199.80 M(-6.3%)
Mar 2018
-
$213.26 M(+144.5%)
Dec 2017
$87.23 M(+846.4%)
$87.23 M(-2.7%)
Sept 2017
-
$89.63 M(+1424.1%)
June 2017
-
$5.88 M(-57.3%)
Mar 2017
-
$13.78 M(+49.5%)
Dec 2016
$9.22 M(-74.5%)
$9.22 M(-44.9%)
Sept 2016
-
$16.73 M(-26.0%)
June 2016
-
$22.62 M(-23.9%)
Mar 2016
-
$29.74 M(-17.7%)
Dec 2015
$36.13 M(+115.4%)
$36.13 M(-14.8%)
Sept 2015
-
$42.42 M(+114.7%)
June 2015
-
$19.76 M(-5.1%)
Mar 2015
-
$20.83 M(+24.2%)
Dec 2014
$16.77 M(-26.3%)
$16.77 M(-42.9%)
Sept 2014
-
$29.37 M(+151.5%)
June 2014
-
$11.68 M(-24.2%)
Mar 2014
-
$15.41 M(-32.3%)
Dec 2013
$22.75 M(-328.4%)
$22.75 M
Dec 2012
-$9.96 M
-

FAQ

  • What is CymaBay Therapeutics annual working capital?
  • What is the all time high annual working capital for CymaBay Therapeutics?
  • What is CymaBay Therapeutics annual working capital year-on-year change?
  • What is CymaBay Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for CymaBay Therapeutics?
  • What is CymaBay Therapeutics quarterly working capital year-on-year change?

What is CymaBay Therapeutics annual working capital?

The current annual working capital of CBAY is $366.96 M

What is the all time high annual working capital for CymaBay Therapeutics?

CymaBay Therapeutics all-time high annual working capital is $366.96 M

What is CymaBay Therapeutics annual working capital year-on-year change?

Over the past year, CBAY annual working capital has changed by +$244.33 M (+199.24%)

What is CymaBay Therapeutics quarterly working capital?

The current quarterly working capital of CBAY is $366.96 M

What is the all time high quarterly working capital for CymaBay Therapeutics?

CymaBay Therapeutics all-time high quarterly working capital is $427.99 M

What is CymaBay Therapeutics quarterly working capital year-on-year change?

Over the past year, CBAY quarterly working capital has changed by -$61.03 M (-14.26%)